日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B)

BRCA1/2 逆转突变在日本转移性乳腺癌患者中发生,且在接受奥拉帕尼治疗后病情进展:OLIVE (WJOG15321B)

Sakai, Hitomi; Kusumoto-Matsuo, Rika; Hosonaga, Mari; Nozawa, Kazuki; Futamura, Manabu; Tanabe, Yuko; Mukohara, Toru; Shiraishi, Kazuhiro; Toyama, Tatsuya; Yasojima, Hiroyuki; Watanabe, Noriyuki; Sakai, Hideki; Iwasa, Tsutomu; Takeuchi, Nobumichi; Tada, Hiroshi; Sakai, Kazuko; Chiba, Natsuko; Takano, Toshimi; Tsurutani, Junji

Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention in heart failure with reduced ejection fraction: a Markov model using JROAD-DPC cost data in Japan

植入式心脏复律除颤器用于射血分数降低型心力衰竭一级预防的成本效益分析:基于日本JROAD-DPC成本数据的马尔可夫模型

Ohashi, Kazuki; Watanabe, Masaya; Morii, Yasuhiro; Yokoshiki, Hisashi; Kusano, Kengo; Imai, Katsuhiko; Takagi, Masahiko; Yamane, Teiichi; Tada, Hiroshi; Ogasawara, Katsuhiko

One-Year Outcome of Japanese Patients With Atrial Fibrillation: Insights From APHRS-AF Registry

日本房颤患者一年预后:来自APHRS-AF注册研究的启示

Yodogawa, Kenji; Iwasaki, Yu-Ki; Okumura, Yasuo; Nagashima, Koichi; Inoue, Koichi; Tanaka, Nobuaki; Kusano, Kengo; Miyamoto, Koji; Takagi, Masahiko; Soejima, Kyoko; Momose, Yuichi; Sakamoto, Tomohiro; Okamatsu, Hideharu; Murohara, Toyoaki; Inden, Yasuya; Fukuda, Keiichi; Takatsuki, Seiji; Kihara, Yasuki; Nakano, Yukiko; Yamane, Teiichi; Tokuda, Michifumi; Ajioka, Masayoshi; Osanai, Hiroyuki; Satomi, Kazuhiro; Tsutsui, Hiroyuki; Shimizu, Akihiko; Sakagami, Satoru; Watanabe, Eiichi; Hagiwara, Nobuhisa; Kawamura, Mitsuharu; Takahashi, Naohiko; Kobayashi, Yoshinori; Tomita, Hirofumi; Tada, Hiroshi; Aonuma, Kazutaka; Koretsune, Yukihiro; Ikeda, Takanori; Goya, Masahiko; Shimizu, Wataru

Utility of echocardiographic parameters in predicting cardiac immune-related adverse events in Japanese patients undergoing immune checkpoint inhibitor therapy

超声心动图参数在预测接受免疫检查点抑制剂治疗的日本患者心脏免疫相关不良事件中的应用价值

Yamaguchi, Junya; Morishita, Tetsuji; Uzui, Hiroyasu; Hasegawa, Kanae; Ikeda, Hiroyuki; Tada, Hiroshi

Design and Framework of JROAD-DPC - A Japanese Nationwide Registry Linking Diagnosis Procedure Combination Data With Cardiovascular Quality Metrics

JROAD-DPC 的设计与框架——一个将诊断程序组合数据与心血管质量指标联系起来的日本全国性注册系统

Shibata, Tatsuhiro; Kanaoka, Koshiro; Iwanaga, Yoshitaka; Sumita, Yoko; Matoba, Satoaki; Ieda, Masaki; Yasuda, Satoshi; Kohsaka, Shun; Matoba, Tetsuya; Nakayama, Masaharu; Amano, Tetsuya; Bando, Yasuko K; Enomoto, Mika; Saito, Aya; Tada, Hiroshi; Fukumoto, Yoshihiro

Risk Prediction Models of Cardiotoxicity in Patients With Breast Cancer: Multicenter Prospective CHECK HEART-BC Study

乳腺癌患者心脏毒性风险预测模型:多中心前瞻性 CHECK HEART-BC 研究

Terui, Yosuke; Nochioka, Kotaro; Ota, Hideki; Tada, Hiroshi; Sato, Haruka; Miyata, Satoshi; Toyoda, Shigeru; Inami, Shu; Nomura, Akihiro; Shimojima, Masaya; Izumiya, Yasuhiro; Kodama, Yusuke; Kitai, Takeshi; Iwabuchi, Kaoru; Suzuki, Shu; Kitano, Daisuke; Kida, Keisuke; Shibuya, Kiyotaka; Oikawa, Takuya; Nabeta, Takeru; Yano, Toshiyuki; Iwano, Hiroyuki; Oikawa, Masayoshi; Shibata, Tatsuhiro; Miura, Yutaka; Ogihara, Yoshito; Komiyama, Nobuyuki; Kato, Hiroshi; Higuchi, Koji; Miyazaki, Sakiko; Yamashita, Yugo; Yasuda, Satoshi; Sugimura, Koichiro

Embolic Stroke After Pulsed Field Ablation for Atrial Fibrillation

房颤脉冲场消融术后发生栓塞性卒中

Sasajima, Kohei; Satomi, Kazuhiro; Yamauchi, Yasuteru; Takatsuki, Seiji; Kamoshida, Junichi; Mukai, Moe; Oda, Atsuhito; Ieda, Masaki; Tada, Hiroshi

Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial

曲妥珠单抗-帕妥珠单抗联合艾立布林或紫杉烷类药物作为人表皮生长因子2阳性局部晚期/转移性乳腺癌的一线化疗方案:随机非劣效性III期EMERALD试验

Yamashita, Toshinari; Saji, Shigehira; Takano, Toshimi; Naito, Yoichi; Tsuneizumi, Michiko; Yoshimura, Akiyo; Takahashi, Masato; Tsurutani, Junji; Iwatani, Tsuguo; Kitada, Masahiro; Tada, Hiroshi; Mori, Natsuko; Higuchi, Toru; Iwasa, Tsutomu; Araki, Kazuhiro; Koizumi, Kei; Hasegawa, Hiroki; Uchida, Yohei; Morita, Satoshi; Masuda, Norikazu

Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis

帕妥珠单抗再治疗人表皮生长因子受体2阳性局部晚期/转移性乳腺癌(PRECIOUS研究):最终总生存期分析

Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira; Takahashi, Masato; Yoshinami, Tetsuhiro; Ueno, Takayuki; Toyama, Tatsuya; Yamanaka, Takashi; Takano, Toshimi; Kashiwaba, Masahiro; Tsugawa, Koichiro; Hasegawa, Yoshie; Tamura, Kenji; Tada, Hiroshi; Hara, Fumikata; Fujisawa, Tomomi; Niikura, Naoki; Taira, Naruto; Morita, Satoshi; Toi, Masakazu; Ohno, Shinji; Masuda, Norikazu

Erratum: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis

更正:帕妥珠单抗再治疗人表皮生长因子受体2阳性局部晚期/转移性乳腺癌(PRECIOUS研究):最终总生存期分析

Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira; Takahashi, Masato; Yoshinami, Tetsuhiro; Ueno, Takayuki; Toyama, Tatsuya; Yamanaka, Takashi; Takano, Toshimi; Kashiwaba, Masahiro; Tsugawa, Koichiro; Hasegawa, Yoshie; Tamura, Kenji; Tada, Hiroshi; Hara, Fumikata; Fujisawa, Tomomi; Niikura, Naoki; Taira, Naruto; Morita, Satoshi; Toi, Masakazu; Ohno, Shinji; Masuda, Norikazu